Ten Chinese Rabies Vaccine For Human Suppliers Popular in European and American Countries

April 11, 2024

The rabies vaccine for humans is witnessing a surge in demand due to increasing awareness about the disease. Technological advancements in vaccine development are leading to more effective and affordable options. Governments are also implementing mass vaccination programs to prevent rabies outbreaks.

Wuhan Institute of Biological Products
Changchun Zhuoyi Biological Co., Ltd
Changchun Institute of Biological Products
Beijing Institute of Biological Products
Sinovac Biotech
Chengdu Institute of Biological Products

Wuhan Institute of Biological Products

Establishment time : 1965

website : http://www.whbp.com.cn

Main Product : vaccines, blood products, and diagnostic reagents

Company Profile

Wuhan Institute of Biological Products is a leading biopharmaceutical company in China, specializing in the production of vaccines, blood products, and diagnostic reagents. With a history dating back to 1965, the company has grown to become a major player in the domestic and international markets. Known for its strong research and development capabilities, Wuhan Institute of Biological Products is a key player in the global vaccine market.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Changchun Institute of Biological Products

Establishment time : 1958

website : http://www.cibp.com.cn/

Main Product : Vaccines, biological products

Company Profile

Changchun Institute of Biological Products is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines and biological products. Established in 1958, the company has grown to become a major player in the industry, with a large production capacity and a strong presence in both domestic and international markets. With a commitment to innovation and quality, CIBP continues to be a leading producer of vaccines, contributing to the improvement of public health worldwide.

Beijing Institute of Biological Products

Establishment time : 1967

website : http://www.bibp.com.cn/

Main Product : Vaccines and biological products

Company Profile

Beijing Institute of Biological Products (BIBP) is a leading biopharmaceutical company in China, specializing in the production of vaccines and biological products. Founded in 1967, BIBP has established itself as a key player in the global healthcare industry, with a strong presence in both domestic and international markets. The company is known for its commitment to research and development, as well as its high-quality products that contribute to public health and disease prevention.

Sinovac Biotech

Establishment time : Sinovac Biotech is a leading biopharmaceutical company specializing in the research, development, production, and commercialization of vaccines.

website :

Main Product : Sinovac's main products include vaccines for diseases such as hepatitis A and B, influenza, and COVID-19.

Company Profile

For more information, visit the company's website at www.sinovac.com.

Chengdu Institute of Biological Products

Establishment time : 1969

website :

Main Product : Biological products, vaccines

Company Profile

Chengdu Institute of Biological Products is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. Founded in 1969, the company has a strong presence in the domestic market and is expanding its reach in Asia. With a focus on innovation and quality, Chengdu Institute of Biological Products is committed to improving public health and advancing medical science.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326